Status: Not yet recruiting
Xenon for Neuroprotection During Post-Cardiac Arrest Syndrome in Comatose Survivors of an Out of Hospital Cardiac Arrest
XePOHCAS: Prospective, randomized, multicenter interventional trial in adult subjects with out-of-hospital cardiac arrest comparing treatment with standard-of-care post-cardiac arrest intensive care (which is targeted temperature management \[TTM\]) to xenon by inhalation plus standard-of-care post-cardiac arrest intensive care (including TTM).
Participants needed: 1,436
Trial details
Phase: Phase 3Age: 18-80Biological sex: AllType: InterventionalSponsor: Invero Pharma, Inc.Updated: Apr 3, 2025Locations: 10
Eligibility criteria
Age at least 18 years but less than or equal to 80 years [+4]
Written do not attempt resuscitation reported to providers before randomization [+19]